Interpace Biosciences, Inc.
corporate_fare Company Profile
Interpace Biosciences, Inc. (OTC:IDXGD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 2 items for IDXGD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-01, rated 7/10. Across its 2 most recent items scored 7 or higher, the top rating is 7/10. Recent SEC coverage for IDXGD spans S-1/A, S-1.
Recent high-impact activity:
- Interpace Biosciences Sets $6.00–$7.00 Price Range for 3.1M-Share Nasdaq Uplist Offering
- Interpace Biosciences Files for $20M Uplisting Offering on Nasdaq
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for IDXGD, detected from its recent SEC filings · based on capital-structure filings through 2026-10-01.
Offering Priced at $6.00–$7.00 · Net Proceeds Estimated at $17.9M
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →